CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

JPMorgan Adjusts Price Target on Incyte to $123 From $120, Keeps Neutral Rating

Neutral
AI Analysis

Summary

JPMorgan adjusted its price target on Incyte from $120 to $123 while maintaining a Neutral rating.

Importance:2/10
Sentiment:
0.00
price targetanalyst ratingstock
Related Companies

Read the original article

Published by yahoo_finance on September 28, 2026 9:47 AM

Read Original